HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

LMW-PTP is a positive regulator of tumor onset and growth.

Abstract
Low molecular weight protein tyrosine phosphatases (LMW-PTPs) are an enzyme family that plays a key role in cell proliferation control by dephosphorylating/inactivating both tyrosine kinase receptors (such as PDGF, insulin, and ephrin receptors) and docking proteins (such, as beta-catenin) endowed with both adhesion and transcriptional activity. Besides being a frequent event in human tumors, overexpression of LMW-PTP has been recently demonstrated to be sufficient to induce neoplastic transformation. We recently demonstrated that overexpression of LMW-PTP strongly potentiates the stability of cell-cell contacts at the adherens junction level, which powerfully suggests that LMW-PTP may also contribute to cancer invasivity. Focusing on mechanisms by which LMW-PTP is involved in cancer onset and progression, the emerging picture is that LMW-PTP strongly increases fibronectin-mediated cell adhesion and mobility but, paradoxically, decreases cell proliferation. Nevertheless, LMW-PTP-transfected NIH3T3 fibroblasts engrafted in nude mice induce the onset of larger fibrosarcomas, which are endowed with higher proliferation activity as compared to mock-transfected controls. Quite opposite effects have been obtained with engrafted fibroblasts transfected with a dominant-negative form of LMW-PTP. Notably, in sarcoma extracts, LMW-PTP overexpression greatly influences the ephrin A2 (EphA2) but not PDGF receptor or beta-catenin tyrosine phosphorylation. The high association of dephosphorylated EphA2 overexpression with most human cancers and our observation that cell growth stimulation by LMW-PTP overexpression is restricted to the in vivo model, strongly suggest that LMW-PTP oncogenic potential is mediated by its EphA2 tyrosine dephosphorylating activity.
AuthorsPaola Chiarugi, Maria Letizia Taddei, Nicola Schiavone, Laura Papucci, Elisa Giannoni, Tania Fiaschi, Sergio Capaccioli, Giovanni Raugei, Giampietro Ramponi
JournalOncogene (Oncogene) Vol. 23 Issue 22 Pg. 3905-14 (May 13 2004) ISSN: 0950-9232 [Print] England
PMID15021900 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Isoenzymes
  • Proto-Oncogene Proteins
  • Receptor, EphA2
  • ACP1 protein, human
  • Acp1 protein, mouse
  • Protein Tyrosine Phosphatases
Topics
  • Animals
  • Isoenzymes (metabolism)
  • Mice
  • Mice, Nude
  • NIH 3T3 Cells
  • Neoplasms (enzymology, metabolism)
  • Protein Tyrosine Phosphatases (metabolism)
  • Proto-Oncogene Proteins
  • Receptor, EphA2 (metabolism)
  • Sarcoma (enzymology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: